Bolenz C, Vogel T, Morakis P, Mayr R, Marx M, Burger M
Klinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Deutschland.
Geschäftsstelle Qualitätskonferenzen bei der Klinischen Landesregisterstelle (KLR) des Krebsregisters Baden-Württemberg bei der Baden-Württembergischen Krankenhausgesellschaft e. V., Stuttgart, Deutschland.
Urologe A. 2021 Mar;60(3):291-300. doi: 10.1007/s00120-021-01454-3. Epub 2021 Feb 9.
Urologic cancer care needs to be prioritized despite multiple health care restrictions during the coronavirus disease 2019 (COVID-19) pandemic. However, therapies and procedures may be delayed and complicated. In Germany, analysis of the multiple cancer registries provides insights into the actual numbers of treated patients. We provide a review on the registration of urologic cancer care during the first wave of the COVID-19 pandemic in Germany and on potential surgical complications of urologic interventions. We found that during the year 2020 there were generally fewer registrations of newly diagnosed patients with major urologic neoplasms in a representative federal database. The number of surgical interventions in patients with renal cell carcinoma and urothelial bladder cancer decreased, whereas equal numbers of radical prostatectomies were performed when compared to the year 2019. COVID-19 may increase non-urological postoperative complications following surgical treatment of urologic malignancies; however, available data are still very limited.
在2019年冠状病毒病（COVID-19）大流行期间，尽管存在多项医疗保健限制，但泌尿生殖系统癌症护理仍需优先考虑。然而，治疗和手术可能会延迟且变得复杂。在德国，对多个癌症登记处的分析有助于了解实际接受治疗的患者数量。我们对德国COVID-19大流行第一波期间泌尿生殖系统癌症护理的登记情况以及泌尿生殖系统干预措施的潜在手术并发症进行了综述。我们发现，2020年在一个具有代表性的联邦数据库中，新诊断的主要泌尿生殖系统肿瘤患者的登记数量总体上有所减少。肾细胞癌和尿路上皮膀胱癌患者的手术干预数量减少，而与2019年相比，根治性前列腺切除术的实施数量持平。COVID-19可能会增加泌尿生殖系统恶性肿瘤手术治疗后的非泌尿生殖系统术后并发症；然而，现有数据仍然非常有限。
